Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Emergent Biosolutions (NY: EBS ) 8.770 -0.350 (-3.84%) Official Closing Price Updated: 4:10 PM EST, Nov 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Emergent Biosolutions < Previous 1 2 3 4 5 6 7 8 9 ... 13 14 Next > Emergent BioSolutions Appoints Dr. Simon Lowry as Chief Medical Officer and Head of Research and Development Today 7:30 EST From Emergent BioSolutions Via GlobeNewswire Emergent BioSolutions to Release Third Quarter 2024 Financial Results and Conduct Conference Call on November 6, 2024 October 23, 2024 From Emergent BioSolutions Via GlobeNewswire Emergent BioSolutions Demonstrates Commitment to Increasing Access & Awareness of NARCAN® Nasal Spray to Help Combat the Opioid Epidemic October 08, 2024 From Emergent BioSolutions Via GlobeNewswire (EBS) - Analyzing Emergent BioSolutions's Short Interest August 20, 2024 Via Benzinga 7 Analysts Assess Emergent BioSolutions: What You Need To Know August 16, 2024 Via Benzinga What's Going On With Emergent BioSolutions Stock Wednesday? October 02, 2024 Emergent BioSolutions stock is trading higher after the company announced the closing of a $100 million asset-backed revolving loan facility. Via Benzinga Emergent BioSolutions Announces Closing of $100 Million Asset-Backed Loan Facility October 02, 2024 From Emergent BioSolutions Via GlobeNewswire 12 Health Care Stocks Moving In Thursday's Intraday Session September 26, 2024 Via Benzinga Emergent BioSolutions Announces the Execution of Contract Options Valued at $67.4 Million to Procure Additional TEMBEXA® (brincidofovir) to Support National Preparedness Efforts September 26, 2024 From Emergent BioSolutions Via GlobeNewswire Emergent BioSolutions Confirms Orders Worth $400M Related To Smallpox, Mpox Vaccines September 25, 2024 Emergent BioSolutions secures $400M in orders for smallpox and mpox products, receives FDA approval for ACAM2000's expanded use, and updates its 2024 revenue forecast while beating Q2 sales estimates. Via Benzinga Exposures Product Safety Emergent BioSolutions Confirms Approximately $400 million in Orders in 2024 & 2025 to Support Smallpox and Mpox Preparedness Efforts September 25, 2024 $185+ million in incremental orders for ACAM2000® and VIGIV to be delivered in 2024 and 2025 From Emergent BioSolutions Via GlobeNewswire Emergent BioSolutions Announces Agreement to Settle Securities Class Action Litigation September 13, 2024 From Emergent BioSolutions Via GlobeNewswire Emergent BioSolutions Awarded Research and Development Option valued at $41.9 Million for continued Advanced Development and Procurement of Ebanga™ Treatment for Ebola September 12, 2024 From Emergent BioSolutions Via GlobeNewswire Methanex, Merck And Other Big Stocks Moving Lower In Monday's Pre-Market Session September 09, 2024 Via Benzinga Emergent BioSolutions Successfully Refinances Debt & Further Strengthens Financial Profile September 03, 2024 New favorable terms position Emergent for sustainable, long-term growth, as part of its multi-year plan to stabilize, turnaround and transform the company From Emergent BioSolutions Via GlobeNewswire 12 Health Care Stocks Moving In Monday's Pre-Market Session September 02, 2024 Via Benzinga Emergent BioSolutions Stock Storms Higher After The FDA Signs Off On Mpox Vaccine August 30, 2024 Emergent BioSolutions stock jumped early Friday. Via Investor's Business Daily Exposures Product Safety Emergent BioSolutions Expands Ready to Rescue Initiative to Support Widespread Opioid Emergency Preparedness August 30, 2024 From Emergent BioSolutions Via GlobeNewswire Mpox Vaccine: Emergent BioSolutions' Smallpox Vaccine Gets FDA Nod For Expanded Use For Individuals At High Risk Of Mpox Infection August 30, 2024 The FDA has approved Emergent BioSolutions' supplemental Biologics License Application for ACAM2000 to include the prevention of mpox disease in high-risk individuals, with the approval based on human... Via Benzinga Exposures Product Safety Why MongoDB Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket August 30, 2024 Via Benzinga Emergent BioSolutions’ ACAM2000®, (Smallpox and Mpox (Vaccinia) Vaccine, Live) Receives U.S. FDA Approval for Mpox Indication; Public Health Mpox Outbreak Continues Across Africa & Other Regions August 29, 2024 From Emergent BioSolutions Via GlobeNewswire WHO Seeks $135M In Funding To Fight Mpox: Outbreak 'Can Be Controlled, And Can Be Stopped' August 26, 2024 To fight the mpox outbreak in Africa, the World Health Organization calls for funding help for its six-month plan. Via Benzinga Macy's Reports Weak Sales, Joins JD.com And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session August 21, 2024 Via Benzinga Emergent BioSolutions Finalizes Sale of Baltimore-Camden Manufacturing Site to Bora Pharmaceuticals August 20, 2024 From Emergent BioSolutions Via GlobeNewswire Emergent BioSolutions Responds to Mpox Public Health Emergency as Cases Surge in Africa August 19, 2024 From Emergent BioSolutions Via GlobeNewswire 3 Promising Vaccine Stocks To Watch In The Event Of A Mpox Surge August 19, 2024 Mpox rerun is making these stocks soar. But a non-vaccine approach could yield greater gains. Via Talk Markets Why Emergent BioSolutions Stock Is Skyrocketing Today August 16, 2024 Concerns about the mpox outbreak are causing Emergent BioSolutions' shares to jump. Via The Motley Fool H&R Block Posts Upbeat Earnings, Joins Alibaba Group, CI&T And Other Big Stocks Moving Higher On Friday August 16, 2024 Via Benzinga Why Greenland Technologies Shares Are Trading Higher By Around 40%; Here Are 20 Stocks Moving Premarket August 16, 2024 Via Benzinga Emergent Biosolutions, Bavarian Nordic, GeoVax And SIGA Technologies Shares Are Making Big Moves Thursday: What's Going On? August 15, 2024 Several healthcare stocks associated with mpox are seeing increased attention Thursday after the World Health Organization declared a public health emergency in response to an mpox outbreak in Africa. Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 ... 13 14 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
